Skip to content

The Secret Trail of Moon (Serious Videogame) and Chess on ADHD: a Clinal Trial

Randomized Study of Personalized Cognitive Training With Virtual Reality Technology (The Secret Trail of Moon) Versus Online Therapeutic Chess Cognitive Training Versus Usual Treatment (TAU) in Attention Deficit Hyperactivity Disorder (ADHD):a Clinical Trial

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04355065
Enrollment
105
Registered
2020-04-21
Start date
2019-12-09
Completion date
2021-01-22
Last updated
2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention Deficit Disorder With Hyperactivity

Keywords

Attention deficit hyperactivity disorder, Serious videogames, Cognitive training, Chess

Brief summary

Blackground: Currently research on alternative forms of cognitive training in patients diagnosed with ADHD is gaining interest. Especially, the use of Virtual Reality video games. Our team has developed an innovative video game based on Virtual Reality, The Secret Trail of Moon (TSTM) as a cognitive tool to train 5 main areas of deficit in patients with ADHD. It is superiority study comparing TSTM with therapeutic chess and control group. Methods: This study is prospective, unicentric, randomized with a control group. 105 patients diagnosed with ADHD and pharmacologically stable, aged between 12 and 22 years. These patients will be randomized intro three groups: TSTM group (The Secret Trail of Moon); TC group (Therapeutic Chess) and CG (Control Group). Objective and subjective measures of the patient, parents and teachers will be included. Patients´visit will be different for each group. The TSTM group will have 15 face-to face visits: pre-inclusion visit, inclusion visit, 12 training visits and final visit. CT and GC group patients will have 3 face-to- face visits (pre-inclusion, initial visit and final visit) and 12 email or phone communications during training. Discussion: This study aims to demonstrate the added efficacy of cognitive training to drug treatment. It is a study that tries to demonstrate the superiority of cognitive training with TSTM compared to a traditional cognitive training (TC) and a control group. TSTM is presented as a new and powerful cognitive tool thanks to four factors that make it unique: the feeling of immersion in the scenarios, the variety of mechanics, the personalization and the playful aspect.

Interventions

BEHAVIORALCognitive Traning with The Secret Trail of Moon

Patients are pharmacologically stable and receive a cognitive intervention with our videogame once a week in the hospital.

BEHAVIORALCognitive Traning with Therapeutic Chess

This group is pharmacologically stable. This group performs cognitive training through a therapeutic chess protocol designed by a chess psychologist. The training is done from home and we contact them weekly to correct the exercises done and to follow up.

DRUGControl Group

These patients continue their stable pharmacological treatment and do not receive any additional cognitive intervention. They are contacted weekly by phone to follow up on the group.

Sponsors

Instituto de Salud Carlos III
CollaboratorOTHER_GOV
Ministerio de Economía y Competitividad, Spain
CollaboratorOTHER_GOV
Gammera Nest Technology Company
CollaboratorUNKNOWN
Puerta de Hierro University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

The study is prospective, unicentric, ramdominated, superiority with a control group and with a sample of 105 patients diagnosed with ADHD and pharmacologically stable.

Eligibility

Sex/Gender
ALL
Age
12 Years to 22 Years
Healthy volunteers
No

Inclusion criteria

* Adolescents and young adults (male and female) between the ages of 12 and 22. * Diagnosis of Attention Deficit Hyperactivity Disorder. * Patients with stable pharmacological treatment for ADHD. * Signature of the informed consent by the patient and their parents.

Exclusion criteria

* A diagnosis of ADHD comorbid with autism spectrum disorder or mental retardation. * Suffering from epilepsy. * Mobility plans in the next 3 months. * Plans to begin other psychological treatment, including cognitive-behavioral psychotherapy in the next 3 months. * Possibility of suicide risk as assessed by the clinician.

Design outcomes

Primary

MeasureTime frameDescription
Behavior rating inventory executive function (BRIEF-2)3 monthsThe BRIEF-2 is a questionnaire designed for the evaluation of executive functions in children and adolescents. It is made up of 63 items with three answer options (never, sometimes and frequently). Its correction provides four general indexes: emotional regulation, cognitive regulation, behavioral regulation and global index of executive function.

Secondary

MeasureTime frameDescription
Teacher and Parent Rating Scale( SNAP-IV)3 monthsThe SNAPIV is a scale for the assessment of ADHD symptoms. It consists of 18 scalar items from 0 to 3, of which 9 assess attention deficit and another 9 assess hyperactive-impulsive component. The cut-off points for attention deficit are 2.56 for teachers and 1.78 for parents. For hyperactivity-impulsivity they are 1.78 for teachers and 1.44 for parents. For both components, the points are 2 for teacher and 1.67 for parents.
The Conners Comprehensive Behaviour Rating Scale (CBRS)3 monthsThe Conners scales are a set of scales for the assessment of patients with ADHD. This revised and abbreviated version of the Conners scale is designed to be answered by parents of children ages 6-18. It consists of 10 items with a Likert type response: 0= not true at all/never; 1= just a little true/occasionally; 2= Pretty much true/often; 3=very much true/very often. The cut-off points are divided by gender. For children, a score above 16 is suspected ADHD. While for girls, a suspected diagnosis of ADHD is from 12 points
Emotional Quotient Inventory: Youth Version.(BarOn EQ-i:YV)3 monthsThe BarOn is a questionnaire that it has 60-question, answered by children and young people from 7 to 18 years old. It provides information on total emotional intelligence, divided into four subscales: intrapersonal, interpersonal, stress management and adaptability. It also provides a general mood scale and other validation scales such as positive impression and inconsistency.
Attention-Deficit Hyperactivity Disorder Rating Scale-5 (ADHD-5)3 monthsThis scale is made up of the 18 symptoms. The symptoms are divided into 9 for inattention, 6 for hyperactivity and 3 for impulsivity. Parents and teachers must answer yes/no to each of them. For its diagnosis, 6 or more of the attention deficit symptoms and/or 6 more of hyperactivity-impulsivity symptoms must be fulfilled. Depending on the symptoms met, the inattentive, hyperactive-impulsive or combined profile is specified.
Conners Continuous Performance Test 3rd Edition (CPT-3)3 monthsThe Conners CPT-3 is a computerized, standardized, and validated application test for different age and gender groups. The test consists of pressing a button each time a letter (target) appears on the screen, except for the letter X (non-target), which should not be pressed. The duration is approximately 14 minutes and the presentation interval between letters is variable (1, 2 and 4 seconds). The test provides results on hits, error of omission (undetected target) and errors of commission (reacted non-target), which are considered a measure of impulsivity. In addition, CPT3-3 provides information on mean reaction time and reaction time variability of hits.
Udvalg für Kliniske Undersolgelser (UKU)3 monthsThe UKU is a tool designed to evaluate possible secondary symptoms that happen during the week. This scale is not included in the assessment phases. Only the TSTM group should complete the scale after each cognitive training session.
TEA Questionnaire for the Evaluation of ADHD and Executive Functions (ATENTO)3 monthsThe ATENTO is a questionnaire in the process of validation that give a complete profile of the clinical symptoms of ADHD. This questionnaire has three parts: the first, with 125 items is common to all ages from 3 to 18 years. The second part, with 40 items had to be filled in if it was a patient from 3 to 6 years old and was not used in our study since the sample started from 7 years old. The third and last part, with 48 items, evaluated the population from 6 to 18 years old. All the items are of the likert type, and the parents can give scores of: 1= never or almost neves; 2= Rarely; 3= Sometimes; 4= Many times; 5= Always or almost always.

Countries

Spain

Contacts

Primary ContactHilario M Blasco-Fontecilla, ID
hmblasco@yahoo.es+34 655214857

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026